Injectable weight-management therapies may be discussed for individuals experiencing: Difficulty losing weight despite diet and exercise Weight-loss plateaus Slower metabolism Increased appetite or frequent cravings The need for additional support during a weight-loss program A consultation helps determine which approach may best support your individual needs
Weight loss during Phase 2 is usually modest, often 1 to 3 pounds depending on starting weight, dietary patterns, and activity level
CrossRef Postacute sequelae of SARS-CoV-2 infection on ophthalmic diseases: a binational cohort study Jee Myung Yang, Hayeon Lee, Jaeyu Park, Min Kim, Ho-Seok Sa, Joo Yong Lee, Kyung Rim Sung, Francesco Branda, Krishna Prasad Acharya, Dong Keon Yon British Journal of Ophthalmology .2026
The frustration is real
Do I need electrolytes on a GLP-1